Omnicyte
Advertisement
OmniCyte is a preclinical stage biotechnology company headquartered in Branford, CT, dedicated to developing targeted treatments for unmet needs in cancer therapy, utilizing its proprietary Immuno-Oncology Platform Technology. The company focuses on various cancer indications, including ovarian cancer, small cell lung cancer, and multiple additional types, leveraging a strong management team and a network of scientific advisors.
With funding sourced from Connecticut Innovations, angel investors, and various research grants, OmniCyte is committed to advancing its targeted immune-oncological therapeutic platform to address some of the most challenging malignancies. The organization aims to innovate in the field of immunomodulators and costimulators to enhance patient outcomes in cancer treatment.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
